CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

New Peer-Reviewed Study Advances CIZ1B Blood Test for Early Lung Cancer Detection

Data ReadoutpositiveCIZ1BPositive
AI Analysis

Summary

Cizzle Bio announced peer-reviewed research supporting CIZ1B blood test for early lung cancer detection and assessment of indeterminate pulmonary nodules. The study advances the company's biomarker-based diagnostic approach.

Outcome Details

Peer-reviewed study supports potential use of CIZ1B blood test for assessing indeterminate pulmonary nodules and guiding diagnostic follow-up

Importance:5/10
Sentiment:
0.60
biomarkerblood testcancer detectionlung cancerearly detectionpeer-reviewed study

Read the original article

Published by PR Newswire Clinical Trials on September 1, 2026 12:00 PM

Read Original